Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target-Reference-Cited by-同舟云学术

Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target

Published:2023-01 Issue:1 Volume:62 Page:77-88
ISSN:1028-4559
Container-title:Taiwanese Journal of Obstetrics and Gynecology
language:en
Short-container-title:Taiwanese Journal of Obstetrics and Gynecology

Author:

Zhang Yixin,Zhang Li,Zhao Yuli,Wang Sen,Feng Li

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference38 articles.

1. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study;Global Burden of Disease 2019 Cancer Collaboration,2019

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J Clin,2021

3. Ovarian cancer statistics;Torre;CA A Cancer J Clin,2018

4. Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: comparison of active surveillance and maintenance treatment;Ray-Coquard;Cancer Treat Rev,2020

5. Coexpression network analysis identified Kruppel-like factor 6 (KLF6) association with chemosensitivity in ovarian cancer;Chen;J Cell Biochem,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. CA 125 for surgico-pathological stage 1 endometrial cancer;Journal of the Chinese Medical Association;2024-02-21

3. Front-line chemoimmunotherapy for treating epithelial ovarian cancer: Part II promising results of phase 2 study of paclitaxel-carboplatin-oregovomab regimen;Taiwanese Journal of Obstetrics and Gynecology;2024-01

4. Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125;Taiwanese Journal of Obstetrics and Gynecology;2023-11

5. Good outcome of endometrial cancer patients coexisting with adenomyosis is a result of their associated favorable clinico-pathological parameters;Taiwanese Journal of Obstetrics and Gynecology;2023-11